Literature DB >> 8345979

Occult blood and fecal leukocytes as screening tests in childhood infectious diarrhea: an old problem revisited.

L Huicho1, D Sanchez, M Contreras, M Paredes, H Murga, L Chinchay, G Guevara.   

Abstract

During a 24-month period 446 children with diarrhea and 16 controls had examination of their stools for leukocytes and for occult blood. Fecal leukocytes were found in 36, 16 and 18% of children with Salmonella-Shigella-Campylobacter, rotavirus or enterotoxigenic Escherichia coli, or cryptosporidial diarrhea, respectively. Similarly 43, 39 and 38% of these groups, respectively, as well as 13% of controls had occult blood. Notably 70% of 10 Shigella cases had fecal leukocytes. In 166 children with mixed pathogens leukocytes were seen in 27 and 8% of children with Salmonella-Shigella-Campylobacter or noninvasive pathogen, respectively. Likewise 44 and 18% of these groups had occult blood. Agreement between both tests being positive was poor, the highest result being 50% for Shigella. Dysentery combined with both tests positive was associated with 15 (88%) cases of invasive agents present in stool cultures, and combination of dysentery with fecal leukocytes was associated with 21 (72%) cases of invasive agents recovered. The results of these tests should be interpreted in the context of the clinical situation. A combined clinical-epidemiologic and screening tests-based approach to infectious diarrhea of childhood is suggested.

Entities:  

Mesh:

Year:  1993        PMID: 8345979     DOI: 10.1097/00006454-199306000-00004

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  10 in total

1.  Performance assessment of the fecal leukocyte test for inpatients.

Authors:  L A Granville; P Cernoch; G A Land; J R Davis
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

2.  Shiga toxin 2 and flagellin from shiga-toxigenic Escherichia coli superinduce interleukin-8 through synergistic effects on host stress-activated protein kinase activation.

Authors:  Dakshina M Jandhyala; Trisha J Rogers; Anne Kane; Adrienne W Paton; James C Paton; Cheleste M Thorpe
Journal:  Infect Immun       Date:  2010-05-03       Impact factor: 3.441

3.  Role of stool screening tests in diagnosis of inflammatory bacterial enteritis and in selection of specimens likely to yield invasive enteric pathogens.

Authors:  R P Silletti; G Lee; E Ailey
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

4.  Immunological testing for occult blood in patients with acute infectious diarrhea. Can it improve the specificity of the guaiac test?

Authors:  J Beltinger; R Walther; P Bardhan; D Mahalanabis; K Gyr
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

5.  Fecal leukocyte stain has diagnostic value for outpatients but not inpatients.

Authors:  K L Savola; E J Baron; L S Tompkins; D J Passaro
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

6.  To culture or not to culture: fecal lactoferrin screening for inflammatory bacterial diarrhea.

Authors:  S W Choi; C H Park; T M Silva; E I Zaenker; R L Guerrant
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

7.  Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea.

Authors:  Cynthia L Sears; Salequl Islam; Amit Saha; Maleka Arjumand; Nur Haque Alam; A S G Faruque; M A Salam; Jai Shin; David Hecht; Andrej Weintraub; R Bradley Sack; Firdausi Qadri
Journal:  Clin Infect Dis       Date:  2008-09-15       Impact factor: 9.079

8.  Is Fecal Leukocyte Test a good predictor of Clostridium difficile associated diarrhea?

Authors:  Savio Reddymasu; Ankur Sheth; Daniel E Banks
Journal:  Ann Clin Microbiol Antimicrob       Date:  2006-04-19       Impact factor: 3.944

9.  Clinical Symptoms of Human Rotavirus Infection Observed in Children in Sokoto, Nigeria.

Authors:  B R Alkali; A I Daneji; A A Magaji; L S Bilbis
Journal:  Adv Virol       Date:  2015-11-25

Review 10.  Acute gastroenteritis.

Authors:  Nancy S Graves
Journal:  Prim Care       Date:  2013-07-19       Impact factor: 2.907

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.